chr17-29566329-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_198147.3(ABHD15):c.638C>A(p.Ser213Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000559 in 1,611,282 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
ABHD15
NM_198147.3 missense
NM_198147.3 missense
Scores
14
5
Clinical Significance
Conservation
PhyloP100: 7.01
Genes affected
ABHD15 (HGNC:26971): (abhydrolase domain containing 15) Predicted to enable acylglycerol lipase activity and short-chain carboxylesterase activity. Predicted to be involved in cellular lipid metabolic process. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
ABHD15-AS1 (HGNC:49685): (ABHD15 antisense RNA 1)
TP53I13 (HGNC:25102): (tumor protein p53 inducible protein 13) Involved in several processes, including negative regulation of cell cycle; response to UV; and response to xenobiotic stimulus. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABHD15 | NM_198147.3 | c.638C>A | p.Ser213Tyr | missense_variant | 1/2 | ENST00000307201.5 | NP_937790.2 | |
TP53I13 | XM_047437003.1 | c.-534G>T | 5_prime_UTR_variant | 1/8 | XP_047292959.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABHD15 | ENST00000307201.5 | c.638C>A | p.Ser213Tyr | missense_variant | 1/2 | 1 | NM_198147.3 | ENSP00000302657 | P1 | |
ABHD15-AS1 | ENST00000581474.1 | n.153+5630G>T | intron_variant, non_coding_transcript_variant | 5 | ||||||
TP53I13 | ENST00000584522.1 | n.29G>T | non_coding_transcript_exon_variant | 1/2 | 4 | |||||
TP53I13 | ENST00000578073.1 | n.177+101G>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152270Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
152270
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000410 AC: 1AN: 244094Hom.: 0 AF XY: 0.00000749 AC XY: 1AN XY: 133498
GnomAD3 exomes
AF:
AC:
1
AN:
244094
Hom.:
AF XY:
AC XY:
1
AN XY:
133498
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1459012Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 725556
GnomAD4 exome
AF:
AC:
3
AN:
1459012
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
725556
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74394
GnomAD4 genome
AF:
AC:
6
AN:
152270
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2023 | The c.638C>A (p.S213Y) alteration is located in exon 1 (coding exon 1) of the ABHD15 gene. This alteration results from a C to A substitution at nucleotide position 638, causing the serine (S) at amino acid position 213 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of disorder (P = 0.0255);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at